Search results

Hundreds of families in the UK are giving their children illegal cannabis products due to a lack of access on the NHS, according to a new report. The research, commissioned by charity Medan Family Foundation, reveals almost 400 families are sourcing illegal cannabis products from drug dealers...

The first medical cannabis products have officially been registered in Ukraine, meaning patients should be able to access treatment in the coming weeks. Curaleaf International has successfully registered three separate oil-based products in the country, which legalised medical cannabis last...

A new study has investigated changes in opioid use in US states which have passed medical and recreational cannabis laws. The study, led by Columbia University Mailman School of Public Health, found no changes in opioid outcomes among the general population following the states’ passage of...

The authors of a new Canadian study have called for increased public funding to protect the ‘scientific integrity’ of cannabis research and reduce reliance on industry sponsorship. Research led by the Centre for Addiction and Mental Health (CAMH) in Canada, sheds light on the ethical...

Inflammatory bowel disease (IBD) patients in the UK have reported improvements in their condition following treatment with medical cannabis. According to observational data published in the journal Expert Review of Gastroenterology & Hepatology, medical cannabis treatment was associated with...

New preliminary research highlights the potential of Ayurvedic medicine combined with medical cannabis as an alternative treatment for menstrual cramps. Results from a Phase 1 clinical trial have found ‘strong preliminary evidence’ to support the safety and efficacy of a new patent-pending...

Thousands of French medical cannabis patients have been given a temporary reprieve, enabling them to continue accessing their treatment for another six months. Amid the continued political chaos in the country, participants in France’s medical cannabis ‘experiment,’ which is now entering its...

In a new study researchers explored whether CBD can reduce scan-related anxiety in patients with advanced breast cancer. The findings showed that while CBD did not significantly change scan-related anxiety when compared to a placebo, it was safe and resulted in significantly lower overall...

Via Business of Cannabis French patient associations have warned that medical cannabis patients could soon face a disruption in treatment as its long-running experiment comes to an end with no next steps in place. The French Society for the Study and Treatment of Pain (SFETD) issued a...

From April 2025, Dutch coffee shops will only be permitted to sell regulated cannabis products, as the next phase of the country’s adult-use pilot gets underway. One year on from the launch of the Netherlands’ Closed Coffee Shop Chain Experiment, regulators have set a fixed date for the...

Jazz Pharmaceuticals has shared new data to support the efficacy of Epidiolex in patients with tuberous sclerosis complex (TSC). Research shared at the American Epilepsy Society (AES) 2024 Annual Meeting held from 6-10 December in Los Angeles, California supports the use of Epidiolex in the...

MAPS (Multidisciplinary Association for Psychedelic Studies) has secured FDA clearance to conduct a clinical trial examining the use of smoked cannabis for the treatment of PTSD symptoms among veterans. After three years of negotiation, the FDA has given MAPS the green light to carry out a...

Via Business of Cannabis In a long-awaited and major step forward for the UK’s CBD sector, the regulator has announced a new roadmap that could see the first products given official approval by Spring next year. While this announcement comes nearly seven years after the novel foods process...

Thousands more doctors in the Czech Republic will soon be permitted to prescribe medical cannabis under a new decree published by the Ministry of Health. From April 2025, the country’s 5,000 general practitioners will be permitted to prescribe medical cannabis to patients with chronic pain...

Via Business of Cannabis UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis research in Europe, announcing the launch of two more major trials using its proprietary compounds. Last month, Business of Cannabis reported that two...

Researchers from the Centre for Reproductive Health at the University of Edinburgh have co-authored a new review paper highlighting the potential of CBD in the treatment of endometriosis. The new paper, published in the top-ranking journal Trends in Pharmacological Science (TIPS), finds that...

A newly-obtained report by France’s Directorate General of Health (DGS) evaluating the impact of the medical cannabis pilot, recommended the roll out of a temporary regulatory framework last year. The Union of Industrialists for the Valorization of Hemp Extracts (UIVEC) in France says the...

Representatives from five European countries, as well as the European Union Drug Agency (EUDA), met in Germany last week to discuss the regulation of cannabis for non-medical purposes. European leaders from Luxembourg, Malta, the Netherlands and Czech Republic attended an international...

Via Business of Cannabis Denmark’s six-year medical cannabis pilot scheme could soon be expanded into a fully legalised market, following a surprise announcement from the government last week. The Danish pilot scheme has been running since 2018, and has continued to expand in both scope and...

Luxembourg is set to restrict access to high-THC cannabis flower on prescription from next year, as part of longer term plans to phase out flower-based products altogether. As of January 2025, patients in Luxembourg will no longer be able to access cannabis flower containing high levels of THC...